🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to investigate the bioequivalence of Mylan ...
Status
Completed
Location
Kendle International Inc.
Start Date
2003-06
Trial ID
NCT00647777
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2003-06
Trial ID
NCT00648921
Treatments Being Tested
The purpose of this study is to compare the bioequivalence and characterize...
Status
Completed
Location
Lambda Therapeutic Research Ltd.,
Start Date
2011-08
Trial ID
NCT01503398
Treatments Being Tested
Open heart surgery, including coronary artery bypass grafting (CABG) and/or...
Status
Recruiting
Location
The Heart Centre, Rigshospitalet
Start Date
2022-11-10
Trial ID
NCT05635227
The purpose of this study is to compare the bioequivalence and characterize...
Status
Completed
Location
Lambda Therapeutic Research Ltd.,
Start Date
2011-08
Trial ID
NCT01503424
Treatments Being Tested
This study was designed to assess the bioequivalence of Olanzapine tablets ...
Status
Completed
Location
QUINTA-ANALYTICA s.r.o.
Start Date
2020-10-21
Trial ID
NCT05123976
Participants who have completed the 6-week trial P05688 can be screened for...
Status
Completed
Location
Forest Investigative Site 2001
Start Date
2012-12
Trial ID
NCT01617200
Treatments Being Tested
Objective: Primary objective of the present study was to compare the singl...
Status
Completed
Location
Bio Evaluation Centre, Torrent Pharmaceuticals Ltd.
Start Date
TBD
Trial ID
NCT01996488
Treatments Being Tested
Objective: Primary objective of the present study was to compare the singl...
Status
Completed
Location
Bio Evaluation Centre, Torrent Pharmaceuticals Ltd.
Start Date
TBD
Trial ID
NCT01996501
Treatments Being Tested